医学
激酶
药理学
药物发现
信号转导
蛋白激酶A
癌症研究
蛋白激酶B
生物
PI3K/AKT/mTOR通路
药物开发
作者
Yangyang Zhang,Minghua Liu,Jun Wang,Jianlin Huang,Mingyue Guo,Ling Zuo,Biantiao Xu,Shousong Cao,Xiukun Lin
标识
DOI:10.2174/1389450120666190802125959
摘要
Protein kinases play critical roles in the control of cell growth, proliferation, migration, and angiogenesis, through their catalytic activity. Over the past years, numerous protein kinase inhibitors have been identified and are being successfully used clinically. Traditional Chinese medicine (TCM) represents a large class of bioactive substances, and some of them display anticancer activity via inhibiting protein kinases signal pathway. Some of the TCM have been used to treat tumors clinically in China for many years. The p38mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase, serine/threonine-specific protein kinases (PI3K/AKT/mTOR), and extracellular signal-regulated kinases (ERK) pathways are considered important signals in cancer cell development. In the present article, the recent progress of TCM that exhibited significant inhibitory activity towards a range of protein kinases is discussed. The clinical efficacy of TCM with inhibitory effects on protein kinases in treating a tumor is also presented. The article also discussed the prospects and problems in the development of anticancer agents with TCM.
科研通智能强力驱动
Strongly Powered by AbleSci AI